Emerging leader in instrumentation products selects clinivation Global xi to manage its medical products approvals and submissions worldwide.
Framingham, MA, March 15, 2007 – clinivation, Inc. announced today that The Anspach Effort, Inc. has selected the clinivation Global Enterprise Solution for Market Clearance Management Market Clearance Management solution.
“Anspach is clearly an emerging leader in the development of instrumentation for various medical applications, and we are excited that Anspach’s management has selected clinivation Global xi to help impact market clearance operations to better achieve sales and marketing objectives,” said Joseph Kozikowski, M.D., clinivation’s Chief Executive Officer.
Clinivation Global xi software enables medical device companies to sell more products to more countries faster and easier than ever before. Clinivation Global xi is the first complete solution targeted at automating the business processes for market clearance operations worldwide.
About The Anspach Effort, Inc.
The Anspach Effort, Inc. is a successful, continuously evolving business whose focus concentrates on high-speed instrumentation for Neurosurgery, Neurotology, Otology, and Orthopedics. We are committed to providing product quality, technology, and service that is best in class.
For more information, visit www.anspach.com.
